オベチコール酸の世界市場レポート 2025年

オベチコール酸市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.1％で16億7,000万米ドルに成長します。予測期間中の成長は、原発性胆汁性胆管炎（PBC）と非アルコール性脂肪性肝炎（NASH）の有病率の増加、革新的な肝疾患治療に対する需要の高まり、肝疾患と利用可能な治療法に対する認識の高まり、新興市場における世界のヘルスケアアクセスの拡大、肝疾患に対する認識への注目の高まりに起因すると考えられます。この期間の主な動向には、NASH治療法の採用、さらなる開発のための提携や共同研究、モニタリングとコンプライアンスのためのデジタルヘルスツールの統合、非アルコール性脂肪性肝疾患（NAFLD）治療へのシフト、肝疾患バイオマーカーの進歩、診断技術の進歩などがあります。

肝疾患の有病率の増加は、オベチコール酸市場の成長を促進すると予想されます。肝疾患は、肝臓の機能を損なう疾患です。このような肝臓疾患の増加は、肝臓細胞を損傷し、炎症、肝硬変、最終的な肝不全につながるアルコールの過剰摂取などの要因に起因しています。オベチコール酸は、ファルネソイドX受容体（FXR）を活性化することにより肝疾患の治療に役立ち、胆汁酸の蓄積を抑え、炎症を減少させ、線維症の進行を遅らせ、肝機能を改善します。例えば、2024年12月、英国の健康改善・格差対策室は、アルコール性肝疾患による早期死亡が3.6％増加し、2022年の5,776人から2023年には5,984人に達すると報告しました。この肝臓病患者の増加がオベチコール酸市場を牽引しています。

オベチコール酸市場で事業を展開する企業は、肝疾患治療と患者の予後を改善するために、FXRアゴニストなどの革新的な製品に取り組んでいます。FXRアゴニストは、肝臓における胆汁酸代謝、炎症、線維化の制御に関与する受容体であるFXRを活性化する化合物です。これらの作動薬は、原発性胆汁性胆管炎（PBC）や非アルコール性脂肪肝炎（NASH）などの疾患の治療に使用され、肝機能の強化に役立っています。例えば、2024年2月、米国のバイオ医薬品会社であるインターセプト・ファーマシューティカルズ・インクは、米国食品医薬品局（FDA）がPBC治療薬オカリバの追加新薬承認申請（sNDA）を受理したと発表しました。FDAの受理は、PBC治療におけるオベチコール酸の臨床的有用性の検証に向けた前進を示すものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のオベチコール酸 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のオベチコール酸市場：成長率分析
• 世界のオベチコール酸市場の実績：規模と成長、2019年～2024年
• 世界のオベチコール酸市場の予測：規模と成長、2024年～2029年、2034年
• 世界のオベチコール酸総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオベチコール酸市場：製品タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 錠剤
• カプセル
• その他の製品タイプ
• 世界のオベチコール酸市場：流通チャネル別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のオベチコール酸市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 原発性胆汁性胆管炎
• 非アルコール性脂肪肝炎
• その他の用途
• 世界のオベチコール酸市場、錠剤の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 即放錠
• 徐放錠
• 世界のオベチコール酸市場、カプセルの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ソフトゼラチンカプセル
• ハードゼラチンカプセル
• 世界のオベチコール酸市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 経口懸濁液
• 注射剤

第7章 地域別・国別分析

• 世界のオベチコール酸市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のオベチコール酸市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オベチコール酸市場：競合情勢
• オベチコール酸市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline（GSK）Overview, Products and Services, Strategy and Financial Analysis
  • Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Genfit Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals
• WuXi AppTec
• Bayer AG
• Sumitomo Dainippon Pharma Co. Ltd.
• Horizon Therapeutics
• Dr. Reddy's Laboratories
• Lupin Limited
• Hepalink Pharmaceutical Group5
• Alembic Pharmaceuticals
• Intercept Pharmaceuticals Inc.
• Enanta Pharmaceuticals
• Viva Life sciences
• Omgene Life Sciences Pvt. Ltd.
• Zydus Cadila

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オベチコール酸市場2029年：新たな機会を提供する国
• オベチコール酸市場2029年：新たな機会を提供するセグメント
• オベチコール酸市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Obeticholic acid is a medication primarily used to treat liver diseases, particularly for patients with primary biliary cholangitis (PBC), a chronic liver condition. It is a synthetic bile acid that activates a receptor called the farnesoid X receptor (FXR), which helps regulate bile acid production, liver function, and inflammation.

The main product types of obeticholic acid include tablets, capsules, and other forms. Tablets are solid dosage forms designed for convenient oral administration. The drug is distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies. It is used to treat nonalcoholic steatohepatitis, primary biliary cholangitis, and other related conditions.

The obeticholic acid market research report is one of a series of new reports from The Business Research Company that provides obeticholic acid market statistics, including the obeticholic acid industry global market size, regional shares, competitors with the obeticholic acid market share, detailed obeticholic acid segments, market trends, and opportunities, and any further data you may need to thrive in the obeticholic acid industry. This obeticholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The obeticholic acid market size has grown rapidly in recent years. It will grow from $0.90 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historic period can be attributed to the increasing prevalence of primary biliary cholangitis (PBC), the rising incidence of non-alcoholic steatohepatitis (NASH), the expansion of healthcare infrastructure in emerging markets, higher rates of liver disease diagnostics and screening, increasing healthcare expenditure, and greater investment in liver disease research.

The obeticholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth during the forecast period can be attributed to the increasing prevalence of primary biliary cholangitis (PBC) and non-alcoholic steatohepatitis (NASH), growing demand for innovative liver disease treatments, rising awareness of liver diseases and available treatments, expansion of global healthcare access in emerging markets, and increasing focus on liver disease awareness. Key trends during this period include the adoption of NASH treatments, partnerships and collaborations for further development, integration of digital health tools for monitoring and compliance, a shift toward non-alcoholic fatty liver disease (NAFLD) treatment, advancements in liver disease biomarkers, and progress in diagnostic technologies.

The increasing prevalence of liver diseases is expected to drive the growth of the obeticholic acid market. Liver diseases are conditions that impair the liver's ability to function effectively. This rise in liver diseases can be attributed to factors such as excessive alcohol consumption, which damages liver cells, leading to inflammation, cirrhosis, and eventual liver failure. Obeticholic acid aids in treating liver disease by activating the farnesoid X receptor (FXR), which helps reduce bile acid buildup, decreases inflammation, and slows fibrosis progression, thereby improving liver function. For example, in December 2024, the UK's Office for Health Improvement and Disparities reported a 3.6% increase in premature deaths from alcoholic liver disease, reaching 5,984 in 2023, up from 5,776 in 2022. This rise in liver disease cases is driving the market for obeticholic acid.

Companies operating in the obeticholic acid market are working on innovative products such as FXR agonists to improve liver disease treatment and patient outcomes. FXR agonists are compounds that activate the FXR, a receptor involved in regulating bile acid metabolism, inflammation, and fibrosis in the liver. These agonists are used to treat conditions such as primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH) and help enhance liver function. For instance, in February 2024, Intercept Pharmaceuticals Inc., a U.S.-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had accepted its supplemental New Drug Application (sNDA) for Ocaliva to treat PBC. The FDA's acceptance indicates progress toward validating the clinical benefits of obeticholic acid for PBC treatment.

In July 2022, Advanz Pharma Corp. Limited, a UK-based pharmaceutical company, acquired Intercept Pharmaceuticals. With this acquisition, Advanz Pharma aimed to strengthen its presence in the specialty pharmaceuticals sector by adding the commercialization rights to Ocaliva (obeticholic acid) for the treatment of PBC. Intercept Pharmaceuticals, a U.S.-based biopharmaceutical company, specializes in providing obeticholic acid.

Major players in the obeticholic acid market are Pfizer Inc., GlaxoSmithKline (GSK), Gilead Sciences Inc., Amgen Inc., Genfit, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, WuXi AppTec, Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Dr. Reddy's Laboratories, Lupin Limited, Hepalink Pharmaceutical Group5, Alembic Pharmaceuticals, Intercept Pharmaceuticals Inc., Enanta Pharmaceuticals, Viva Life sciences, Omgene Life Sciences Pvt. Ltd., Zydus Cadila.

North America was the largest region in the Obeticholic Acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in obeticholic acid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the obeticholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obeticholic acid market consists of sales of products including tablets, generic obeticholic acid, ocaliva support services, patient education kits, and obeticholic acid + ursodeoxycholic acid (UDCA). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obeticholic Acid Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on obeticholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obeticholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The obeticholic acid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablets; Capsules; Other Product Types
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Primary Biliary Cholangitis; Nonalcoholic Steatohepatitis; Other Applications
• Sub Segments:
• 1) By Tablets: Immediate-Release Tablets; Extended-Release Tablets
• 2) By Capsules: Soft Gelatin Capsules; Hard Gelatin Capsules
• 3) By Other Product Types: Oral Suspensions; Injectable Formulations
• Companies Mentioned: Pfizer Inc.; GlaxoSmithKline (GSK); Gilead Sciences Inc.; Amgen Inc.; Genfit
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Obeticholic Acid Market Characteristics

3. Obeticholic Acid Market Trends And Strategies

4. Obeticholic Acid Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Obeticholic Acid Growth Analysis And Strategic Analysis Framework

• 5.1. Global Obeticholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Obeticholic Acid Market Growth Rate Analysis
• 5.4. Global Obeticholic Acid Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Obeticholic Acid Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Obeticholic Acid Total Addressable Market (TAM)

6. Obeticholic Acid Market Segmentation

• 6.1. Global Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Other Product Types
• 6.2. Global Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.3. Global Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Biliary Cholangitis
• Nonalcoholic Steatohepatitis
• Other Applications
• 6.4. Global Obeticholic Acid Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Extended-Release Tablets
• 6.5. Global Obeticholic Acid Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soft Gelatin Capsules
• Hard Gelatin Capsules
• 6.6. Global Obeticholic Acid Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Suspensions
• Injectable Formulations

7. Obeticholic Acid Market Regional And Country Analysis

• 7.1. Global Obeticholic Acid Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Obeticholic Acid Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Obeticholic Acid Market

• 8.1. Asia-Pacific Obeticholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Obeticholic Acid Market

• 9.1. China Obeticholic Acid Market Overview
• 9.2. China Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Obeticholic Acid Market

• 10.1. India Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Obeticholic Acid Market

• 11.1. Japan Obeticholic Acid Market Overview
• 11.2. Japan Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Obeticholic Acid Market

• 12.1. Australia Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Obeticholic Acid Market

• 13.1. Indonesia Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Obeticholic Acid Market

• 14.1. South Korea Obeticholic Acid Market Overview
• 14.2. South Korea Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Obeticholic Acid Market

• 15.1. Western Europe Obeticholic Acid Market Overview
• 15.2. Western Europe Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Obeticholic Acid Market

• 16.1. UK Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Obeticholic Acid Market

• 17.1. Germany Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Obeticholic Acid Market

• 18.1. France Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Obeticholic Acid Market

• 19.1. Italy Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Obeticholic Acid Market

• 20.1. Spain Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Obeticholic Acid Market

• 21.1. Eastern Europe Obeticholic Acid Market Overview
• 21.2. Eastern Europe Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Obeticholic Acid Market

• 22.1. Russia Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Obeticholic Acid Market

• 23.1. North America Obeticholic Acid Market Overview
• 23.2. North America Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Obeticholic Acid Market

• 24.1. USA Obeticholic Acid Market Overview
• 24.2. USA Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Obeticholic Acid Market

• 25.1. Canada Obeticholic Acid Market Overview
• 25.2. Canada Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Obeticholic Acid Market

• 26.1. South America Obeticholic Acid Market Overview
• 26.2. South America Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Obeticholic Acid Market

• 27.1. Brazil Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Obeticholic Acid Market

• 28.1. Middle East Obeticholic Acid Market Overview
• 28.2. Middle East Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Obeticholic Acid Market

• 29.1. Africa Obeticholic Acid Market Overview
• 29.2. Africa Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Obeticholic Acid Market Competitive Landscape And Company Profiles

• 30.1. Obeticholic Acid Market Competitive Landscape
• 30.2. Obeticholic Acid Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. GlaxoSmithKline (GSK) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Genfit Overview, Products and Services, Strategy and Financial Analysis

31. Obeticholic Acid Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Regeneron Pharmaceuticals
• 31.3. WuXi AppTec
• 31.4. Bayer AG
• 31.5. Sumitomo Dainippon Pharma Co. Ltd.
• 31.6. Horizon Therapeutics
• 31.7. Dr. Reddy's Laboratories
• 31.8. Lupin Limited
• 31.9. Hepalink Pharmaceutical Group5
• 31.10. Alembic Pharmaceuticals
• 31.11. Intercept Pharmaceuticals Inc.
• 31.12. Enanta Pharmaceuticals
• 31.13. Viva Life sciences
• 31.14. Omgene Life Sciences Pvt. Ltd.
• 31.15. Zydus Cadila

32. Global Obeticholic Acid Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Obeticholic Acid Market

34. Recent Developments In The Obeticholic Acid Market

35. Obeticholic Acid Market High Potential Countries, Segments and Strategies

• 35.1 Obeticholic Acid Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Obeticholic Acid Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Obeticholic Acid Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer